Epigenetic GABAergic targets in schizophrenia and bipolar disorder.
about
The involvement of Reelin in neurodevelopmental disorders.In Sickness and in Health: Perineuronal Nets and Synaptic Plasticity in Psychiatric DisordersSmall molecule inhibitors of zinc-dependent histone deacetylasesCurrent status and future prospects for epigenetic psychopharmacologyActive DNA demethylation in post-mitotic neurons: a reason for optimismEpigenetic mechanisms in mood disorders: targeting neuroplasticityMice that lack the C-terminal region of Reelin exhibit behavioral abnormalities related to neuropsychiatric disorders.Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell ViabilityMetabotropic Glutamate 2/3 Receptors and Epigenetic Modifications in Psychotic Disorders: A ReviewDissecting bipolar disorder complexity through epigenomic approachTreatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychoticsGrowth arrest and DNA-damage-inducible, beta (GADD45b)-mediated DNA demethylation in major psychosisAntidepressants inhibit DNA methyltransferase 1 through reducing G9a levelsSearching human brain for mechanisms of psychiatric disorders. Implications for studies on schizophrenia.Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice.Advancing drug discovery for schizophrenia.Distinct phenotypes of new transmembrane-domain neuregulin 1 mutant mice and the rescue effects of valproate on the observed schizophrenia-related cognitive deficitsBehavioral and molecular neuroepigenetic alterations in prenatally stressed mice: relevance for the study of chromatin remodeling properties of antipsychotic drugsTheranostic Biomarkers for SchizophreniaPI3K/AKT/mTOR Signaling Mediates Valproic Acid-Induced Neuronal Differentiation of Neural Stem Cells through Epigenetic Modifications.Genetics of schizophrenia from a clinicial perspective.Epigenetic mechanisms during ageing and neurogenesis as novel therapeutic avenues in human brain disorders.DNA-methylation gene network dysregulation in peripheral blood lymphocytes of schizophrenia patients.Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson's disease.Modeling the molecular epigenetic profile of psychosis in prenatally stressed mice.Redox-based epigenetic status in drug addiction: a potential contributor to gene priming and a mechanistic rationale for metabolic intervention.Activation of group II metabotropic glutamate receptors promotes DNA demethylation in the mouse brain.Extracellular matrix abnormalities in schizophreniaDNA-methyltransferase1 (DNMT1) binding to CpG rich GABAergic and BDNF promoters is increased in the brain of schizophrenia and bipolar disorder patients.Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice.Losing the sugar coating: potential impact of perineuronal net abnormalities on interneurons in schizophrenia.Gadd45b and N-methyl-D-aspartate induced DNA demethylation in postmitotic neurons.Epigenetic management of major psychosis.Epigenetic Regulation of Glutamic Acid Decarboxylase 67 in a Hippocampal Circuit.Maternal immune activation produces neonatal excitability defects in offspring hippocampal neurons from pregnant rats treated with poly I:CThe dynamics of DNA methylation in schizophrenia and related psychiatric disorders.Stress-induced epigenetic transcriptional memory of acetylcholinesterase by HDAC4.DNA Methylation of BDNF Gene in Schizophrenia.DNA methylation in schizophrenia: progress and challenges of epigenetic studiesEpigenetic control of neurotransmitter expression in olfactory bulb interneurons.
P2860
Q24632484-9D4B706B-7F5F-4D6A-8C4A-D726BE3E6163Q26769948-477C26C5-29EE-45BE-BB78-AAC72AFD3E34Q26824515-27F6FF4D-87C2-4AD0-A05A-3BF8512EE3F5Q26825464-7EC35326-81E4-4D3E-A985-C706562A3EC8Q26829515-2A22A412-124D-485B-A0EA-915ACD5013ACQ27021810-895F9633-E47E-4C2C-B059-16518A7F93AAQ27334994-129CFB76-C35D-49AB-ABDA-90C27EF093A9Q27679266-1DCB82BE-942B-475B-93C3-D9D785846C8DQ28070122-4AC9C915-23CB-4C1E-A357-FDA4FA8AD550Q28076508-2041B3EB-7A38-444F-B4DD-6D21656DD237Q28079065-2EADDCF2-13F2-452A-8DD1-7384368E1EC0Q28394929-EAB47302-1EEA-4356-86D8-07F0D7A7AF02Q28564940-8011AFFC-A91A-4BA4-8220-BE5EFE69760AQ30375488-7F8A266C-B4CE-4819-BAF8-67590D42D964Q30439246-F9F27E8B-E914-47D4-9CD0-068C35BD61FDQ30448547-1AB13521-19FD-46FC-9C71-CFAC1CE5C7B4Q30576705-D1B0E0B9-EDC8-4EB1-9DC5-F23231813485Q30823912-38D251A9-E494-44EE-894B-A86631947AAFQ33624412-BCC55C59-F089-4F9E-9D90-12B13170684AQ33659344-96158DB2-DBC7-4AC4-895A-497BE3CD6D1FQ33729022-A4C80F77-2D28-43B2-8E5B-D4B33EC1B245Q33858861-35867EBF-2924-4A2E-A602-FCA5CD390818Q34002660-B7E663DE-78C5-4F96-924C-428816B6FF97Q34301607-4EFA1066-59E4-438A-A8E9-89744380B726Q34815864-BD209683-28AA-402F-BF9C-8378E3DE4CA0Q34999412-639ED128-4A3A-427B-B1E4-8727A39912F5Q35080459-12C2D243-F9ED-4D51-B193-9E5B8A9E5272Q35603175-59A21B28-D185-427E-8928-31A75BC96EC6Q35672194-8073EBA1-42E5-4014-AC01-4B0AF7471539Q35760210-BEE73F73-54E0-4D46-AA4B-3AAF3761D26BQ35858830-4083BBDC-5434-4733-8006-478C75EBA23AQ35903252-C5E649C9-7D54-40D0-950A-1FE802D892ADQ36001875-49D5BA8E-3150-4B6D-B90B-FD484EF2C5F7Q36161984-96B5EA15-BC67-4299-9213-E1B5483EC3E7Q36442698-292BE883-A2C6-4ABB-AED8-2F1198B6AB5BQ36465820-6CF212AD-EF6C-4B7A-90DC-5A69A72FE148Q36504453-7FF2A393-98C4-4CAA-9029-7F895F2720EBQ36567277-0E73340E-84D7-4988-A6FA-2A50059CF673Q36632924-9CB73303-F04E-483D-B03F-755448FB8C46Q36756118-377A63E5-B4AF-4430-804D-3BB2FC94F7FC
P2860
Epigenetic GABAergic targets in schizophrenia and bipolar disorder.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Epigenetic GABAergic targets in schizophrenia and bipolar disorder.
@ast
Epigenetic GABAergic targets in schizophrenia and bipolar disorder.
@en
Epigenetic GABAergic targets in schizophrenia and bipolar disorder.
@nl
type
label
Epigenetic GABAergic targets in schizophrenia and bipolar disorder.
@ast
Epigenetic GABAergic targets in schizophrenia and bipolar disorder.
@en
Epigenetic GABAergic targets in schizophrenia and bipolar disorder.
@nl
prefLabel
Epigenetic GABAergic targets in schizophrenia and bipolar disorder.
@ast
Epigenetic GABAergic targets in schizophrenia and bipolar disorder.
@en
Epigenetic GABAergic targets in schizophrenia and bipolar disorder.
@nl
P2093
P2860
P1433
P1476
Epigenetic GABAergic targets in schizophrenia and bipolar disorder.
@en
P2093
A Guidotti
D R Grayson
F Matrisciano
L Tremolizzo
P2860
P304
P356
10.1016/J.NEUROPHARM.2010.10.021
P577
2010-11-11T00:00:00Z